SINOVAC BIOTECH LTD.

(SVA)
  Report
Delayed Nasdaq  -  04:00 2019-02-22 pm EST
6.470 USD   -0.31%
12:59aSinovac's COVID-19 vaccine conditionally registered in South Africa
RE
12:31aSINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
BU
12:30aSinovac Biotech Ltd. Announces South African Health Products Regulatory Authority Granted Conditional Registration to SINOVAC CoronaVac
CI
SummaryQuotesChartsNewsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CDH Utopia Limited entered into an agreement to acquire a 6.07% stake in Sinovac Biotech Ltd. from 1Globe Biomedical (Hong Kong) Company Limited for $90 million.

12/21/2020 EDT

CDH Utopia Limited entered into an agreement to acquire a 6.07% stake in Sinovac Biotech Ltd. (NasdaqGS:SVA) from 1Globe Biomedical (Hong Kong) Company Limited for $90 million on November 24, 2020. Under the term, CDH Utopia will acquire 6 million shares of Sinovac Biotech at $15 per share. CDH Utopia Limited and 1Globe Biomedical (Hong Kong) Company Limited agrees to pay $0.15 million as termination fee. CDH Investment Advisory Private Limited acted as a guarantor to CDH Utopia Limited.


© S&P Capital IQ 2020
All news about SINOVAC BIOTECH LTD.
12:59aSinovac's COVID-19 vaccine conditionally registered in South Africa
RE
12:31aSINOVAC COVID-19 Vaccine Is Conditionally Registered In South Africa
BU
12:30aSinovac Biotech Ltd. Announces South African Health Products Regulatory Authority Grant..
CI
06/09SINOVAC BIOTECH : Polio Vaccine Prequalified by WHO - Form 6-K
PU
06/09Sinovac Biotech Ltd. Polio Vaccine Prequalified by WHO
CI
06/08SINOVAC Polio Vaccine Prequalified by WHO
BU
05/06SINOVAC Updates the Status Under Holding Foreign Companies Accountable Act
BU
05/02SINOVAC BIOTECH : Press Release - Form 6-K
PU
04/29SINOVAC Reports Unaudited Second Half of 2021 Financial Results and Files 2021 Annual R..
BU
04/29Sinovac Biotech Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
CI
More news
Financials (USD)
Sales 2021 19 375 M - -
Net income 2021 8 467 M - -
Net cash 2021 13 270 M - -
P/E ratio 2021 0,09x
Yield 2021 -
Capitalization 642 M 642 M -
EV / Sales 2020 -0,78x
EV / Sales 2021 -0,65x
Nbr of Employees 4 281
Free-Float 67,4%
Chart SINOVAC BIOTECH LTD.
Duration : Period :
Sinovac Biotech Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Wei Dong Yin Chairman, President, CEO, Secretary & MD
Nan Wang CFO & Vice President-Business Development
Qiang Gao Chief Operating Officer & Vice President
Yuk Lam Lo Independent Director
Jian Li Independent Director
Sector and Competitors
1st jan.Capi. (M$)
SINOVAC BIOTECH LTD.0.00%642
CSL LIMITED-6.70%90 814
SAMSUNG BIOLOGICS CO.,LTD.-7.97%45 825
WUXI BIOLOGICS (CAYMAN) INC.-16.59%41 498
BIOGEN INC.-11.67%31 038
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.-19.19%24 084